Nicotinamide riboside attenuates age-associated metabolic and functional changes in hematopoietic stem cells
Aged hematopoietic stem cells (HSC) are characterised by reduced regenerative potential and a loss of quiescence. Here, the authors show nicotinamide riboside treatment shrinks the age-enlarged stem cell pool and shifts aged HSC functionally, metabolically and molecularly towards the young state.
Guardado en:
Autores principales: | Xuan Sun, Benjamin Cao, Marina Naval-Sanchez, Tony Pham, Yu Bo Yang Sun, Brenda Williams, Shen Y. Heazlewood, Nikita Deshpande, Jinhua Li, Felix Kraus, James Rae, Quan Nguyen, Hamed Yari, Jan Schröder, Chad K. Heazlewood, Madeline Fulton, Jessica Hatwell-Humble, Kaustav Das Gupta, Ronan Kapetanovic, Xiaoli Chen, Matthew J. Sweet, Robert G. Parton, Michael T. Ryan, Jose M. Polo, Christian M. Nefzger, Susan K. Nilsson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a2cd09ff347c4623848c6acc6789d348 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
por: Joanna Ratajczak, et al.
Publicado: (2016) -
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
por: Samuel A. J. Trammell, et al.
Publicado: (2016) -
Nicotinamide riboside kinase structures reveal new pathways to NAD+.
por: Wolfram Tempel, et al.
Publicado: (2007) -
Endogenous nicotinamide riboside metabolism protects against diet-induced liver damage
por: Audrey Sambeat, et al.
Publicado: (2019) -
NAD+ augmentation with nicotinamide riboside improves lymphoid potential of Atm −/− and old mice HSCs
por: Le Zong, et al.
Publicado: (2021)